{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:48:15Z","timestamp":1790470095383,"version":"4.1.0"},"reference-count":110,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"vor","delay-in-days":1398,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Nowadays, more than 90% of patients affected by chronic myeloid leukemia (CML) survive with a good quality of life, thanks to the clinical efficacy of tyrosine kinase inhibitors (TKIs). Nevertheless, point mutations of the ABL1 pocket occurring during treatment may reduce binding of TKIs, being responsible of about 20% of cases of resistance among CML patients. In addition, the presence of leukemic stem cells (LSCs) represents the most important event in leukemia progression related to TKI resistance. LSCs express stem cell markers, including active efflux pumps and genetic and epigenetic alterations together with deregulated cell signaling pathways involved in self-renewal, such as Wnt\/\u03b2-catenin, Notch, and Hedgehog. Moreover, the interaction with the bone marrow microenvironment, also known as hematopoietic niche, may influence the phenotype of surrounding cells, which evade mechanisms controlling cell proliferation and are less sensitive or frankly resistant to TKIs. This Review focuses on the role of LSCs and stem cell niche in relation to response to pharmacological treatments. A literature search from PubMed database was performed until April 30, 2017, and it has been analyzed according to keywords such as chronic myeloid leukemia, stem cell, leukemic stem cells, hematopoietic niche, tyrosine kinase inhibitors, and drug resistance.<\/jats:p>","DOI":"10.1002\/sctm.17-0175","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T12:46:40Z","timestamp":1518094000000},"page":"305-314","source":"Crossref","is-referenced-by-count":58,"title":["Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment"],"prefix":"10.1093","volume":"7","author":[{"given":"Elena","family":"Arrigoni","sequence":"first","affiliation":[{"name":"a Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Del Re","sequence":"additional","affiliation":[{"name":"a Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Galimberti","sequence":"additional","affiliation":[{"name":"b Unit of Hematology, Department of Clinical and Experimental Medicine University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Restante","sequence":"additional","affiliation":[{"name":"a Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Rofi","sequence":"additional","affiliation":[{"name":"a Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Crucitta","sequence":"additional","affiliation":[{"name":"a Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Barat\u00e8","sequence":"additional","affiliation":[{"name":"b Unit of Hematology, Department of Clinical and Experimental Medicine University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Petrini","sequence":"additional","affiliation":[{"name":"b Unit of Hematology, Department of Clinical and Experimental Medicine University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romano","family":"Danesi","sequence":"additional","affiliation":[{"name":"a Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"Di Paolo","sequence":"additional","affiliation":[{"name":"a Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,2,8]]},"reference":[{"key":"2022022808501072000_sct312284-bib-0001","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1038\/bcj.2011.35","article-title":"Further phenotypic characterization of the primitive lineage- CD34+CD38-CD90+CD45RA- hematopoietic stem cell\/progenitor cell sub-population isolated from cord blood, mobilized peripheral blood and patients with chronic myelogenous leukemia","volume":"1","author":"Wisniewski","year":"2011","journal-title":"Blood Cancer J"},{"key":"2022022808501072000_sct312284-bib-0002","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1182\/blood-2003-12-4111","article-title":"The biology of CML blast crisis","volume":"103","author":"Calabretta","year":"2004","journal-title":"Blood"},{"key":"2022022808501072000_sct312284-bib-0003","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat Med"},{"key":"2022022808501072000_sct312284-bib-0004","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2010-12-326843","article-title":"Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival","volume":"119","author":"Hamilton","year":"2012","journal-title":"Blood"},{"key":"2022022808501072000_sct312284-bib-0005","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1182\/blood.V94.6.2056","article-title":"Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia","volume":"94","author":"Holyoake","year":"1999","journal-title":"Blood"},{"key":"2022022808501072000_sct312284-bib-0006","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"2022022808501072000_sct312284-bib-0007","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrclinonc.2016.139","article-title":"Tyrosine kinase inhibitors in chronic myeloid leukaemia: Which, when, for whom?","volume":"14","author":"Rosti","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"2022022808501072000_sct312284-bib-0008","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/eci.12368","article-title":"DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia","volume":"44","author":"Valent","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"2022022808501072000_sct312284-bib-0009","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/10245330500234195","article-title":"Evolving molecular therapy for chronic myeloid leukaemia\u2013are we on target?","volume":"10","author":"Copland","year":"2005","journal-title":"Hematology"},{"key":"2022022808501072000_sct312284-bib-0010","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/sj.leu.2404609","article-title":"Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies","volume":"21","author":"Jiang","year":"2007","journal-title":"Leukemia"},{"key":"2022022808501072000_sct312284-bib-0011","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1182\/blood-2009-05-222471","article-title":"Properties of CD34+ CML stem\/progenitor cells that correlate with different clinical responses to imatinib mesylate","volume":"116","author":"Jiang","year":"2010","journal-title":"Blood"},{"key":"2022022808501072000_sct312284-bib-0012","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2141.2008.07197.x","article-title":"Emerging stem cell concepts for imatinib-resistant chronic myeloid leukaemia: Implications for the biology, management, and therapy of the disease","volume":"142","author":"Valent","year":"2008","journal-title":"Br J Haematol"},{"key":"2022022808501072000_sct312284-bib-0013","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1200\/JCO.2008.17.5745","article-title":"Chronic myeloid leukemia stem cells","volume":"26","author":"Kavalerchik","year":"2008","journal-title":"J Clin Oncol"},{"key":"2022022808501072000_sct312284-bib-0014","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J Clin Invest"},{"key":"2022022808501072000_sct312284-bib-0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1172\/JCI43605","article-title":"BCR-ABL kinase is dead; long live the CML stem cell","volume":"121","author":"Perl","year":"2011","journal-title":"J Clin Invest"},{"key":"2022022808501072000_sct312284-bib-0016","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"2022022808501072000_sct312284-bib-0017","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.molonc.2010.06.001","article-title":"Targeting leukemic stem cells by breaking their dormancy","volume":"4","author":"Essers","year":"2010","journal-title":"Mol Oncol"},{"key":"2022022808501072000_sct312284-bib-0018","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/leu.2008.246","article-title":"Targeting the leukemic stem cell: The Holy Grail of leukemia therapy","volume":"23","author":"Misaghian","year":"2009","journal-title":"Leukemia"},{"key":"2022022808501072000_sct312284-bib-0019","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1155\/2008\/146871","article-title":"Stem cell biomarkers in chronic myeloid leukemia","volume":"24","author":"Jiang","year":"2008","journal-title":"Dis Markers"},{"key":"2022022808501072000_sct312284-bib-0020","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood.V88.6.2162.bloodjournal8862162","article-title":"Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia","volume":"88","author":"Petzer","year":"1996","journal-title":"Blood"},{"key":"2022022808501072000_sct312284-bib-0021","doi-asserted-by":"crossref","first-page":"16280","DOI":"10.1073\/pnas.1004408107","article-title":"Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein","volume":"107","author":"Jaras","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022022808501072000_sct312284-bib-0022","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3324\/haematol.2010.035006","article-title":"CD34(+)\/CD38(-) stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab\/ozogamicin","volume":"97","author":"Herrmann","year":"2012","journal-title":"Haematologica"},{"key":"2022022808501072000_sct312284-bib-0023","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10428190500272507","article-title":"Detection of molecular targets on the surface of CD34+\/CD38\u2013 stem cells in various myeloid malignancies","volume":"47","author":"Florian","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"2022022808501072000_sct312284-bib-0024","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1634\/stemcells.20-3-259","article-title":"Immature leukemic CD34+CXCR4+ cells from CML patients have lower integrin-dependent migration and adhesion in response to the chemokine SDF-1","volume":"20","author":"Peled","year":"2002","journal-title":"Stem Cells"},{"key":"2022022808501072000_sct312284-bib-0025","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood-2013-10-536078","article-title":"Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia","volume":"123","author":"Herrmann","year":"2014","journal-title":"Blood"},{"key":"2022022808501072000_sct312284-bib-0026","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/cyto.b.20403","article-title":"Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia","volume":"74B","author":"Figueiredo-Pontes","year":"2008","journal-title":"Cytometry B Clin Cytom"},{"key":"2022022808501072000_sct312284-bib-0027","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1038\/bcj.2016.78","article-title":"Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors","volume":"6","author":"Venton","year":"2016","journal-title":"Blood Cancer J"},{"key":"2022022808501072000_sct312284-bib-0028","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","article-title":"Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML","volume":"351","author":"Jamieson","year":"2004","journal-title":"N Engl J Med"},{"key":"2022022808501072000_sct312284-bib-0029","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/bph.12183","article-title":"Targeting survival pathways in chronic myeloid leukaemia stem cells","volume":"169","author":"Sinclair","year":"2013","journal-title":"Br J Pharmacol"},{"key":"2022022808501072000_sct312284-bib-0030","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1349-7006.2010.01584.x","article-title":"Novel therapeutic approach to eradicate tyrosine kinase inhibitor resistant chronic myeloid leukemia stem cells","volume":"101","author":"Naka","year":"2010","journal-title":"Cancer Sci"},{"key":"2022022808501072000_sct312284-bib-0031","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1182\/asheducation-2008.1.436","article-title":"Chronic myeloid leukemia stem cells","volume":"2008","author":"Jamieson","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2022022808501072000_sct312284-bib-0032","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nature03319","article-title":"Wnt signalling in stem cells and cancer","volume":"434","author":"Reya","year":"2005","journal-title":"Nature"},{"key":"2022022808501072000_sct312284-bib-0033","doi-asserted-by":"crossref","first-page":"15859","DOI":"10.1007\/s13277-016-5413-3","article-title":"Potential role of Wnt\/beta-catenin signaling in blastic transformation of chronic myeloid leukemia: Cross talk between beta-catenin and BCR-ABL","volume":"37","author":"Hu","year":"2016","journal-title":"Tumour Biol"},{"key":"2022022808501072000_sct312284-bib-0034","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1182\/blood-2009-05-222836","article-title":"Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia","volume":"115","author":"Nakahara","year":"2010","journal-title":"Blood"},{"key":"2022022808501072000_sct312284-bib-0035","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/35077219","article-title":"The Hedgehog and Wnt signalling pathways in cancer","volume":"411","author":"Taipale","year":"2001","journal-title":"Nature"},{"key":"2022022808501072000_sct312284-bib-0036","first-page":"781","article-title":"Promotion of the self-renewal capacity of human leukemia cells by sonic hedgehog protein","volume":"31","author":"Kawaguchi-Ihara","year":"2011","journal-title":"Anticancer Res"},{"key":"2022022808501072000_sct312284-bib-0037","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nature07737","article-title":"Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia","volume":"458","author":"Zhao","year":"2009","journal-title":"Nature"},{"key":"2022022808501072000_sct312284-bib-0038","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.febslet.2007.11.025","article-title":"The FoxO transcription factors and metabolic regulation","volume":"582","author":"Nakae","year":"2008","journal-title":"FEBS Lett"},{"key":"2022022808501072000_sct312284-bib-0039","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stem.2007.02.001","article-title":"Foxo3a is essential for maintenance of the hematopoietic stem cell pool","volume":"1","author":"Miyamoto","year":"2007","journal-title":"Cell Stem Cell"},{"key":"2022022808501072000_sct312284-bib-0040","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature08734","article-title":"TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia","volume":"463","author":"Naka","year":"2010","journal-title":"Nature"},{"key":"2022022808501072000_sct312284-bib-0041","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1084\/jem.20110304","article-title":"BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia","volume":"208","author":"Hurtz","year":"2011","journal-title":"J Exp Med"},{"key":"2022022808501072000_sct312284-bib-0042","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3324\/haematol.2013.098442","article-title":"Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: Possible new targets of therapy","volume":"99","author":"Bibi","year":"2014","journal-title":"Haematologica"},{"key":"2022022808501072000_sct312284-bib-0043","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/leu.2008.27","article-title":"Targeting survival cascades induced by activation of Ras\/Raf\/MEK\/ERK, PI3K\/PTEN\/Akt\/mTOR and Jak\/STAT pathways for effective leukemia therapy","volume":"22","author":"McCubrey","year":"2008","journal-title":"Leukemia"},{"key":"2022022808501072000_sct312284-bib-0044","doi-asserted-by":"crossref","first-page":"23937","DOI":"10.18632\/oncotarget.14893","article-title":"Aurora kinases: Novel therapy targets in cancers","volume":"8","author":"Tang","year":"2017","journal-title":"Oncotarget"},{"key":"2022022808501072000_sct312284-bib-0045","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1172\/JCI68951","article-title":"PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells","volume":"123","author":"Neviani","year":"2013","journal-title":"J Clin Invest"},{"key":"2022022808501072000_sct312284-bib-0046","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ng.389","article-title":"Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia","volume":"41","author":"Chen","year":"2009","journal-title":"Nat Genet"},{"key":"2022022808501072000_sct312284-bib-0047","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/leu.2016.53","article-title":"Aberrant activation of CaMKIIgamma accelerates chronic myeloid leukemia blast crisis","volume":"30","author":"Gu","year":"2016","journal-title":"Leukemia"},{"key":"2022022808501072000_sct312284-bib-0048","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/nature07016","article-title":"PML targeting eradicates quiescent leukaemia-initiating cells","volume":"453","author":"Ito","year":"2008","journal-title":"Nature"},{"key":"2022022808501072000_sct312284-bib-0049","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s13238-015-0143-7","article-title":"Leukemia stem cells: The root of chronic myeloid leukemia","volume":"6","author":"Zhou","year":"2015","journal-title":"Protein Cell"},{"key":"2022022808501072000_sct312284-bib-0050","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bcmd.2014.07.002","article-title":"BMI1 gene expression in myeloid leukemias and its impact on prognosis","volume":"53","author":"Saudy","year":"2014","journal-title":"Blood Cells Mol Dis"},{"key":"2022022808501072000_sct312284-bib-0051","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature01572","article-title":"Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells","volume":"423","author":"Lessard","year":"2003","journal-title":"Nature"},{"key":"2022022808501072000_sct312284-bib-0052","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00277-008-0603-8","article-title":"BMI-1 expression is enhanced through transcriptional and posttranscriptional regulation during the progression of chronic myeloid leukemia","volume":"88","author":"Bhattacharyya","year":"2009","journal-title":"Ann Hematol"},{"key":"2022022808501072000_sct312284-bib-0053","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1182\/blood-2010-02-270660","article-title":"BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells","volume":"116","author":"Rizo","year":"2010","journal-title":"Blood"},{"key":"2022022808501072000_sct312284-bib-0054","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2217\/epi.15.35","article-title":"Polycomb genes are associated with response to imatinib in chronic myeloid leukemia","volume":"7","author":"Crea","year":"2015","journal-title":"Epigenomics"},{"key":"2022022808501072000_sct312284-bib-0055","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1182\/blood.V93.6.2075.406k29_2075_2080","article-title":"Methylation of the ABL1 promoter in chronic myelogenous leukemia: Lack of prognostic significance","volume":"93","author":"Issa","year":"1999","journal-title":"Blood"},{"key":"2022022808501072000_sct312284-bib-0056","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1476-4598-9-44","article-title":"A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers","volume":"9","author":"Dunwell","year":"2010","journal-title":"Mol Cancer"},{"key":"2022022808501072000_sct312284-bib-0057","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1038\/sj.onc.1210610","article-title":"Histone deacetylases and cancer","volume":"26","author":"Glozak","year":"2007","journal-title":"Oncogene"},{"key":"2022022808501072000_sct312284-bib-0058","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc2562","article-title":"How does SIRT1 affect metabolism, senescence and cancer?","volume":"9","author":"Brooks","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"2022022808501072000_sct312284-bib-0059","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.exphem.2016.02.007","article-title":"Regain control of p53: Targeting leukemia stem cells by isoform-specific HDAC inhibition","volume":"44","author":"Kuo","year":"2016","journal-title":"Exp Hematol"},{"key":"2022022808501072000_sct312284-bib-0060","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1182\/blood-2011-06-361691","article-title":"Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis","volume":"119","author":"Yuan","year":"2012","journal-title":"Blood"},{"key":"2022022808501072000_sct312284-bib-0061","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/onc.2012.83","article-title":"SIRT1 deacetylase promotes acquisition of genetic mutations for drug resistance in CML cells","volume":"32","author":"Wang","year":"2013","journal-title":"Oncogene"},{"key":"2022022808501072000_sct312284-bib-0062","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/MOH.0000000000000152","article-title":"Role of SIRT1 in the growth and regulation of normal hematopoietic and leukemia stem cells","volume":"22","author":"Li","year":"2015","journal-title":"Curr Opin Hematol"},{"key":"2022022808501072000_sct312284-bib-0063","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1002\/stem.2218","article-title":"CD150(-) side population defines leukemia stem cells in a BALB\/c mouse model of CML and is depleted by genetic loss of SIRT1","volume":"33","author":"Wang","year":"2015","journal-title":"Stem Cells"},{"key":"2022022808501072000_sct312284-bib-0064","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1476-4598-10-41","article-title":"Expression patterns of microRNAs associated with CML phases and their disease related targets","volume":"10","author":"Machova Polakova","year":"2011","journal-title":"Mol Cancer"},{"key":"2022022808501072000_sct312284-bib-0065","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bcmd.2014.02.008","article-title":"ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance","volume":"53","author":"Ferreira","year":"2014","journal-title":"Blood Cells Mol Dis"},{"key":"2022022808501072000_sct312284-bib-0066","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/cas.12339","article-title":"Downregulation of miR-217 correlates with resistance of Ph(+) leukemia cells to ABL tyrosine kinase inhibitors","volume":"105","author":"Nishioka","year":"2014","journal-title":"Cancer Sci"},{"key":"2022022808501072000_sct312284-bib-0067","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.canlet.2014.10.006","article-title":"MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR-ABL protein","volume":"356","author":"Hershkovitz-Rokah","year":"2015","journal-title":"Cancer Lett"},{"key":"2022022808501072000_sct312284-bib-0068","doi-asserted-by":"crossref","first-page":"49451","DOI":"10.18632\/oncotarget.17706","article-title":"Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells","volume":"8","author":"Salati","year":"2017","journal-title":"Oncotarget"},{"key":"2022022808501072000_sct312284-bib-0069","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nbt.1607","article-title":"Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML","volume":"28","author":"Saito","year":"2010","journal-title":"Nat Biotechnol"},{"key":"2022022808501072000_sct312284-bib-0070","first-page":"1","article-title":"One more stem cell niche: How the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a \u201chypoxic\u201d environment","volume":"2","author":"Rovida","year":"2014","journal-title":"Hypoxia (Auckl)"},{"key":"2022022808501072000_sct312284-bib-0071","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/nm909","article-title":"Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia","volume":"9","author":"Matsunaga","year":"2003","journal-title":"Nat Med"},{"key":"2022022808501072000_sct312284-bib-0072","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12984","article-title":"The bone marrow niche for haematopoietic stem cells","volume":"505","author":"Morrison","year":"2014","journal-title":"Nature"},{"key":"2022022808501072000_sct312284-bib-0073","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1242\/jcs.074112","article-title":"The haematopoietic stem cell niche at a glance","volume":"124","author":"Lo Celso","year":"2011","journal-title":"J Cell Sci"},{"key":"2022022808501072000_sct312284-bib-0074","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1084\/jem.192.9.1365","article-title":"The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells","volume":"192","author":"Karanu","year":"2000","journal-title":"J Exp Med"},{"key":"2022022808501072000_sct312284-bib-0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1478-811X-11-33","article-title":"Targeting self-renewal pathways in myeloid malignancies","volume":"11","author":"Sands","year":"2013","journal-title":"Cell Commun Signal"},{"key":"2022022808501072000_sct312284-bib-0076","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1182\/blood-2016-11-696070","article-title":"The microenvironment in human myeloid malignancies: Emerging concepts and therapeutic implications","volume":"129","author":"Medyouf","year":"2017","journal-title":"Blood"},{"key":"2022022808501072000_sct312284-bib-0077","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081824","article-title":"Chemokines as a conductor of bone marrow microenvironment in chronic myeloid leukemia","volume":"18","author":"Mukaida","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2022022808501072000_sct312284-bib-0078","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1182\/blood-2008-10-184754","article-title":"Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization","volume":"114","author":"Christopher","year":"2009","journal-title":"Blood"},{"key":"2022022808501072000_sct312284-bib-0079","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1158\/1535-7163.MCT-07-0042","article-title":"CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells","volume":"7","author":"Jin","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"2022022808501072000_sct312284-bib-0080","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ccr.2012.02.018","article-title":"Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia","volume":"21","author":"Zhang","year":"2012","journal-title":"Cancer Cell"},{"key":"2022022808501072000_sct312284-bib-0081","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1158\/0008-5472.CAN-06-3166","article-title":"Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells","volume":"67","author":"Tabe","year":"2007","journal-title":"Cancer Res"},{"key":"2022022808501072000_sct312284-bib-0082","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nm.3647","article-title":"Hematopoietic stem cell niche maintenance during homeostasis and regeneration","volume":"20","author":"Mendelson","year":"2014","journal-title":"Nat Med"},{"key":"2022022808501072000_sct312284-bib-0083","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1182\/blood.V85.12.3636.bloodjournal85123636","article-title":"Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: Role of malignant stromal macrophages","volume":"85","author":"Bhatia","year":"1995","journal-title":"Blood"},{"key":"2022022808501072000_sct312284-bib-0084","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s12185-017-2184-6","article-title":"Regulation of normal and leukemic stem cells through cytokine signaling and the microenvironment","volume":"105","author":"Camacho","year":"2017","journal-title":"Int J Hematol"},{"key":"2022022808501072000_sct312284-bib-0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ccr.2009.02.016","article-title":"JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal","volume":"15","author":"Santaguida","year":"2009","journal-title":"Cancer Cell"},{"key":"2022022808501072000_sct312284-bib-0086","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40164-016-0062-1","article-title":"Loss of quiescence and self-renewal capacity of hematopoietic stem cell in an in vitro leukemic niche","volume":"6","author":"Vanegas","year":"2017","journal-title":"Exp Hematol Oncol"},{"key":"2022022808501072000_sct312284-bib-0087","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/leu.2016.34","article-title":"TGF-alpha and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapy","volume":"30","author":"Nievergall","year":"2016","journal-title":"Leukemia"},{"key":"2022022808501072000_sct312284-bib-0088","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/leu.2017.91","article-title":"The emerging roles of tumor-derived exosomes in hematological malignancies","volume":"31","author":"Boyiadzis","year":"2017","journal-title":"Leukemia"},{"key":"2022022808501072000_sct312284-bib-0089","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fimmu.2014.00160","article-title":"Plasma exosomes as markers of therapeutic response in patients with acute myeloid leukemia","volume":"5","author":"Hong","year":"2014","journal-title":"Front Immunol"},{"key":"2022022808501072000_sct312284-bib-0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12964-015-0086-x","article-title":"Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism","volume":"13","author":"Raimondo","year":"2015","journal-title":"Cell Commun Signal"},{"key":"2022022808501072000_sct312284-bib-0091","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.canlet.2014.03.009","article-title":"Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an interleukin 8-dependent survival of leukemia cells","volume":"348","author":"Corrado","year":"2014","journal-title":"Cancer Lett"},{"key":"2022022808501072000_sct312284-bib-0092","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1182\/blood.V87.9.4016.bloodjournal8794016","article-title":"Serum interleukin-8 (IL-8) and IL-6 concentrations in patients with hematologic malignancies","volume":"87","author":"Denizot","year":"1996","journal-title":"Blood"},{"key":"2022022808501072000_sct312284-bib-0093","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1476-4598-13-169","article-title":"Exosomal shuttling of miR-126 in endothelial cells modulates adhesive and migratory abilities of chronic myelogenous leukemia cells","volume":"13","author":"Taverna","year":"2014","journal-title":"Mol Cancer"},{"key":"2022022808501072000_sct312284-bib-0094","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/jcmm.12873","article-title":"Chronic myelogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor","volume":"20","author":"Corrado","year":"2016","journal-title":"J Cell Mol Med"},{"key":"2022022808501072000_sct312284-bib-0095","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood-2013-07-511907","article-title":"Physiologic hypoxia promotes maintenance of CML stem cells despite effective BCR-ABL1 inhibition","volume":"123","author":"Ng","year":"2014","journal-title":"Blood"},{"key":"2022022808501072000_sct312284-bib-0096","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ccr.2011.05.007","article-title":"Loss or inhibition of stromal-derived PlGF prolongs survival of mice with imatinib-resistant Bcr-Abl1(+) leukemia","volume":"19","author":"Schmidt","year":"2011","journal-title":"Cancer Cell"},{"key":"2022022808501072000_sct312284-bib-0097","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1080\/17425255.2016.1215423","article-title":"ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: An overview","volume":"12","author":"Arrigoni","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2022022808501072000_sct312284-bib-0098","doi-asserted-by":"crossref","first-page":"7496","DOI":"10.1038\/sj.onc.1206950","article-title":"Transcriptional regulation of ABC drug transporters","volume":"22","author":"Scotto","year":"2003","journal-title":"Oncogene"},{"key":"2022022808501072000_sct312284-bib-0099","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1158\/1078-0432.CCR-11-1590","article-title":"Molecular pathways: Regulation and therapeutic implications of multidrug resistance","volume":"18","author":"Chen","year":"2012","journal-title":"Clin Cancer Res"},{"key":"2022022808501072000_sct312284-bib-0100","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbagen.2015.12.011","article-title":"Multidrug resistant tumour cells shed more microvesicle-like EVs and less exosomes than their drug-sensitive counterpart cells","volume":"1860","author":"Lopes-Rodrigues","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"2022022808501072000_sct312284-bib-0101","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2210-10-12","article-title":"Hematopoietic stem cells exhibit a specific ABC transporter gene expression profile clearly distinct from other stem cells","volume":"10","author":"Tang","year":"2010","journal-title":"BMC Pharmacol"},{"key":"2022022808501072000_sct312284-bib-0102","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1038\/sj.leu.2404859","article-title":"ATP-binding-cassette transporters in hematopoietic stem cells and their utility as therapeutical targets in acute and chronic myeloid leukemia","volume":"21","author":"Raaijmakers","year":"2007","journal-title":"Leukemia"},{"key":"2022022808501072000_sct312284-bib-0103","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/sj.leu.2403257","article-title":"P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate","volume":"18","author":"Illmer","year":"2004","journal-title":"Leukemia"},{"key":"2022022808501072000_sct312284-bib-0104","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1134\/S0006297908010045","article-title":"Role of P-glycoprotein in evolution of populations of chronic myeloid leukemia cells treated with imatinib","volume":"73","author":"Stromskaya","year":"2008","journal-title":"Biochemistry (Mosc)"},{"key":"2022022808501072000_sct312284-bib-0105","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1182\/blood-2004-04-1398","article-title":"Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)\/ABCG2 drug pump","volume":"104","author":"Burger","year":"2004","journal-title":"Blood"},{"key":"2022022808501072000_sct312284-bib-0106","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1158\/1078-0432.CCR-07-4913","article-title":"Interaction of imatinib with human organic ion carriers","volume":"14","author":"Hu","year":"2008","journal-title":"Clin Cancer Res"},{"key":"2022022808501072000_sct312284-bib-0107","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.leukres.2014.12.008","article-title":"Drug transporters play a key role in the complex process of Imatinib resistance in vitro","volume":"39","author":"Alves","year":"2015","journal-title":"Leuk Res"},{"key":"2022022808501072000_sct312284-bib-0108","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3109\/10428191003596835","article-title":"Antisense oligonucleotide against miR-21 inhibits migration and induces apoptosis in leukemic K562 cells","volume":"51","author":"Hu","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"2022022808501072000_sct312284-bib-0109","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1756-9966-30-110","article-title":"miR-15a and miR-16-1 inhibit the proliferation of leukemic cells by down-regulating WT1 protein level","volume":"30","author":"Gao","year":"2011","journal-title":"J Exp Clin Cancer Res"},{"key":"2022022808501072000_sct312284-bib-0110","doi-asserted-by":"crossref","first-page":"25476","DOI":"10.1038\/srep25476","article-title":"Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia","volume":"6","author":"Irvine","year":"2016","journal-title":"Sci Rep"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fsctm.17-0175","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/7\/3\/305\/42625324\/stcltm_7_3_305.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/7\/3\/305\/42625324\/stcltm_7_3_305.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T08:53:23Z","timestamp":1646038403000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/7\/3\/305\/6454836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,8]]},"references-count":110,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,2,8]]},"published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.1002\/sctm.17-0175","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,3,1]]},"published":{"date-parts":[[2018,2,8]]}}}